Search research articles
Contact Us
Filters
Showing results (641-650 of 688) with videos related to
Page
of 69
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Basic Science and Pathogenesis
Elizabeth J Andrews, Phong T Ngo, Jesse R Pascual, et al.
Plos One
|
March 4, 2021
Sildenafil-evoked photoreceptor oxidative stress in vivo is unrelated to impaired visual performance in mice
Bruce A Berkowitz, Robert H Podolsky, Karen Lins Childers, et al.
International Journal of Molecular Sciences
|
April 28, 2023
Sickle Cell Hemoglobin Genotypes Affect Malaria Parasite Growth and Correlate with Exosomal miR-451a and let-7i-5p Levels
Keri Oxendine Harp, Alaijah Bashi, Felix Botchway, et al.
Science Advances
|
January 2, 2026
STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance
Joseph R Podojil, Andrew C Cogswell, Tobias Neef, et al.
Journal of Medicinal Chemistry
|
October 30, 2013
Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)
Patrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Neurology
|
July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosis
Raju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
Ebiomedicine
|
June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials
Amit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Plos One
|
March 2, 2011
Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis
Nancy L Monson, Petra Cravens, Rehana Hussain, et al.
Nucleic Acids Research
|
April 17, 2026
Acyclic serinol nucleic acid modification of siRNAs overcomes seed region mediated off-target effects while maintaining potency
Tyler Chickering, Joel M Harp, Yongfeng Jiang, et al.
Clinical and Translational Radiation Oncology
|
May 7, 2020
Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
Sonja Stieb, Abdallah S R Mohamed, Tanaya S Deshpande, et al.
Page
of 69
Search research articles
Search
Showing results (641-650 of 688) with videos related to
Sort By:
Page
of 69
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Basic Science and Pathogenesis
Elizabeth J Andrews, Phong T Ngo, Jesse R Pascual, et al.
Plos One
|
March 4, 2021
Sildenafil-evoked photoreceptor oxidative stress in vivo is unrelated to impaired visual performance in mice
Bruce A Berkowitz, Robert H Podolsky, Karen Lins Childers, et al.
International Journal of Molecular Sciences
|
April 28, 2023
Sickle Cell Hemoglobin Genotypes Affect Malaria Parasite Growth and Correlate with Exosomal miR-451a and let-7i-5p Levels
Keri Oxendine Harp, Alaijah Bashi, Felix Botchway, et al.
Science Advances
|
January 2, 2026
STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance
Joseph R Podojil, Andrew C Cogswell, Tobias Neef, et al.
Journal of Medicinal Chemistry
|
October 30, 2013
Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)
Patrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Neurology
|
July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosis
Raju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
Ebiomedicine
|
June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials
Amit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Plos One
|
March 2, 2011
Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis
Nancy L Monson, Petra Cravens, Rehana Hussain, et al.
Nucleic Acids Research
|
April 17, 2026
Acyclic serinol nucleic acid modification of siRNAs overcomes seed region mediated off-target effects while maintaining potency
Tyler Chickering, Joel M Harp, Yongfeng Jiang, et al.
Clinical and Translational Radiation Oncology
|
May 7, 2020
Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
Sonja Stieb, Abdallah S R Mohamed, Tanaya S Deshpande, et al.
Page
of 69